If we can’t print the trial dose, there is no product.

A list of things we will not do. You can hold us to the numbers.

We only sell ingredients at the dose the evidence actually used.
If we can’t print that dose, we don’t make the bottle.

The label is not a suggestion of what’s inside. It’s the amount, in the unit, matching the amount in the study. Where the study used a range, we print the range and where we sit in it.

Every amount is printed. There are no proprietary blends.

A blend is a way to list an impressive ingredient and hide how little of it you’re getting. We won’t use one. If an amount is embarrassing, that’s information you’re entitled to before you pay — and a reason for us not to include it at all.

We won’t tell you when you’ll notice anything.

Nobody can. Every bottle in your cabinet came with a number of weeks on it, and that number was marketing. We’ll tell you what the trials measured and how long they ran. What happens in your knees on your timeline is not something we get to promise you.

There is no checkout until the standard is met.

No presale. No deposit. No waitlist that takes a card. A company that can take your money before the product exists has already told you what it optimizes for. The absence of a store here is not a launch phase — it’s the standard doing its job.

If the evidence moves, the bottle moves — or it goes away.

Studies get replicated, or they don’t. If the dose behind an ingredient stops holding up, we reformulate or we pull it, and we say which and why on this page. A standard you can only pass once isn’t a standard.